U.S. Department of Defense Grant Programs Advance
Filed with ASX · · 2 pages · English
• Both projects reaffirm Bio-Gene’s alignment with the US Deployed Warfighter Protection (DWFP) program’s objective to develop novel solutions that protect military and civilian populations from insect-borne disease threats Bio-Gene Technology Limited (ASX:BGT, Bio-Gene or the Company), an Australian company developing the next generation of novel insecticides derived from nature, is pleased to pr
Bio-Gene Technology Ltd. on 6ix
Story so far
Earlier from Bio-Gene Technology
- Bio-Gene Receives $519,500 R&D Tax Incentive
- CEO's Presentation
- Chair's Address to Shareholders
- Qcide receives organic listing status in USA
- Response to ASX Aware Letter
Later from Bio-Gene Technology
- Quarterly Activities/Appendix 4C Cash Flow Report
- Appendix 4D and Half-Year Accounts 31 December 2025
- Regulatory Development of Flavocide
- Sumitomo & Nakashima to launch Qcide products in Japan
- Results of Placement
Follow Bio-Gene Technology into a list and get an email when it puts out news.
Follow Bio-Gene Technology